DeepMed Research

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients

Not Applicable

Completed

Conditions: Immunization Status
Well Child Care Visit

Interventions: Other: Letters
Other: Autodialer

First Posted Date: 2010-01-27

Last Posted Date: 2016-01-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 10599

Registration Number: NCT01057888

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

Phase 4

Completed

Conditions: Systemic Sclerosis
Shortness of Breath
Pulmonary Hypertension

Interventions: Drug: Ambrisentan

First Posted Date: 2010-01-20

Last Posted Date: 2020-11-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 12

Registration Number: NCT01051960

Locations: 🇺🇸
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States

POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China

Not Applicable

Completed

Conditions: Patient Satisfaction
HIV-related Stigma
Provider-patient Interaction

Interventions: Behavioral: Cognitive behavioral sessions

First Posted Date: 2010-01-20

Last Posted Date: 2024-03-18

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 5400

Registration Number: NCT01052415

Locations: 🇺🇸
UCLA Semel Institute-Center for Community Health, Los Angeles, California, United States

Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease

Phase 1

Terminated

Conditions: Crohn's Disease
Vitamin D Deficiency

Interventions: Drug: Cholecalciferol

First Posted Date: 2010-01-12

Last Posted Date: 2018-02-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 3

Registration Number: NCT01046773

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Methylphenidate to Treat Methamphetamine Dependence

Phase 2

Conditions: Methamphetamine Dependence

Interventions: Drug: Methylphenidate

First Posted Date: 2010-01-07

Last Posted Date: 2014-05-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 90

Registration Number: NCT01044238

Locations: 🇺🇸
UCLA Integrated Substance Abuse Programs Outpatient Clinical Research Center, Los Angeles, California, United States

Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families

Not Applicable

Completed

Conditions: Quality of Life
Mental Health
Physical Health
Family Relations

Interventions: Behavioral: Cognitive behavioral sessions

First Posted Date: 2009-12-23

Last Posted Date: 2012-02-24

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 1033

Registration Number: NCT01037946

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Effects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled Trial

Phase 2

Completed

Conditions: Weight Reduction
Obesity
Weight Management

Interventions: Dietary Supplement: Herbalife Meal Replacements

First Posted Date: 2009-12-11

Last Posted Date: 2009-12-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 100

Registration Number: NCT01030354

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Spices Inhibit the Formation and Absorption of Malondialdehyde From Hamburger Meat

Not Applicable

Completed

Conditions: NIDDM

Interventions: Other: Hamburger meat patty with spice blend
Other: Hamburger meat patty with salt

First Posted Date: 2009-12-07

Last Posted Date: 2018-10-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 11

Registration Number: NCT01027052

Safety Assessment of Atomoxetine With MA IV Administration

Phase 1

Terminated

Conditions: Methamphetamine Abuse
Methamphetamine Dependence

Interventions: Drug: Atomoxetine, then Placebo
Drug: Placebo, then Atomoxetine

First Posted Date: 2009-11-25

Last Posted Date: 2017-06-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 6

Registration Number: NCT01019707

Locations: 🇺🇸
UCLA Semel Institute NPI, Los Angeles, California, United States

Interventions for Communication in Autism Network

Not Applicable

Completed

Conditions: Autism

Interventions: Behavioral: Interpersonal Developmental Approach
Behavioral: Discrete Trial Training

First Posted Date: 2009-11-23

Last Posted Date: 2024-06-14

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 192

Registration Number: NCT01018407

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy